Effect PMA-Zeolite on the Mineral Metabolism and Blood Parameters (MMBP Study)
NCT04607018 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2020-10-28
Summary
The Panaceo Micro Activation (PMA) -zeolite s a certified medical device throughout the European Union and absorbs defined harmful substances (mainly heavy metals and ammonium ions) in the gastrointestinal tract, while at the same time the alkaline ions contained in the crystal lattice are released (Mg2+, Ca2+, K+, Na+). Through a recent study the main-effect of zeolite was defined (support/ strengthen the intestinal wall barrier) and as a side-effect the measurement of the mineral metabolism was included, without documenting any significant changes. Its potential in releasing minerals needs to be investigated further to broaden the knowledge from previous study-outcomes as described. Broadening this knowledge through measuring defined blood-parameters was the aim of this human trial.
Conditions
- Effects of the Elements
Interventions
- DEVICE
-
PMA-zeolite
subjects received boxes containing PMA-zeolite powder for supplementation for a total of 28 days. Dosage for PMA-zeolite (100% zeolite; 1 ML - spoon for dosage = ca. 3 g zeolite):1 spoon of the powder stirred 2 times daily (morning and evening) in water (1 glass).
Sponsors & Collaborators
-
General Hospital Pula
lead OTHER
Principal Investigators
-
Krešimir Pavelić, Phd, M.D. · Juraj Dobrila University of Pula
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-11-17
- Primary Completion
- 2016-05-13
- Completion
- 2016-06-15
More Related Trials
-
Safety and Efficacy Study of AMG 073 in Hemodialysis Subjects
NCT00527267 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation
NCT00428246 ·Status: COMPLETED ·Phase: NA
-
Renal Metabolism of Glycolate to Oxalate
NCT04437225 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Magnesium Replacement and Hyperglycemia After Kidney Transplantation
NCT04382157 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study Comparing Effects of Lanthanum Carbonate Versus Calcium Acetate Versus Dietary Phosphorus Restriction
NCT01357317 ·Status: UNKNOWN ·Phase: PHASE3
-
Dietary Oxalate and Innate Immunity in Kidney Stone Disease
NCT04051346 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary Hyperparathyroidism
NCT03774771 ·Status: COMPLETED ·Phase: PHASE2
-
Influence of Obesity on Endogenous Oxalate Synthesis
NCT03704350 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Palm Tocotrienols in Chronic Hemodialysis (USA)
NCT02358967 ·Status: COMPLETED ·Phase: NA
-
Oxazyme in Patients With Hyperoxaluria
NCT01127087 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Oxalate-Driven Host Responses in Kidney Stone Disease
NCT05417568 ·Status: RECRUITING ·Phase: NA
-
Effects of Dietary Phosphorus on Phosphorus and Calcium Whole-Body Balance and Kinetics in Moderate CKD
NCT06712719 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis
NCT00042653 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study to Investigate the Effects of Increased Dialysate Magnesium and Dialysate Bicarbonate on the Calcification Propensity of Serum
NCT02621762 ·Status: COMPLETED ·Phase: NA
-
The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular Filtration Rate
NCT01163162 ·Status: COMPLETED ·Phase: PHASE4
-
Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria
NCT00588120 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Endogenous Oxalate Synthesis
NCT05229952 ·Status: COMPLETED ·Phase: NA
-
Analysis of Urine Composition Saturation and Dietary Intervention in Subjects Without Urinary Calculi
NCT05102279 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety, Tolerability, and Clinical Effects of Twice-daily Doses of Cinacalcet (AMG 073) in Adults With Primary Hyperparathyroidism (HPT)
NCT03776058 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Oral Uremic Toxin Absorbent and Probiotics to Retard the Progression of Chronic Kidney Disease
NCT04819217 ·Status: RECRUITING ·Phase: NA
-
Calcium and Phosphorus Balance and Calcium Kinetics in Patients With Stage 3/4 Chronic Kidney Disease
NCT01161407 ·Status: COMPLETED ·Phase: NA
-
Impact of Long-term Serum Magnesium and Potassium Levels Optimization and Multifactorial Adherence Intervention on the Progression of Diabetic Kidney Disease.
NCT04942119 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Increasing Dialysate Magnesium on Calcification Propensity in Subjects on Haemodialysis
NCT02977117 ·Status: COMPLETED ·Phase: PHASE2
-
Oxalate Formation From Ascorbic Acid
NCT04603898 ·Status: RECRUITING ·Phase: NA
-
Topical Magnesium and Muscle Cramps in Dialysis Patients.
NCT03082625 ·Status: UNKNOWN ·Phase: PHASE2